NYSE:PBYI

Puma Biotechnology Stock Signals

etoro logo Buy PBYI
*Your capital is at risk
$4.96
+0.0700 (+1.43%)
At Close: Nov 17, 2025

Latest Data & Signals Issued

Signal Type Signal Value Data
Score -2.056 4 days ( 0.601 % )
Last Price $4.96 1.43 %
High/ Low $4.87 - $5.10 8.21%
Chg 7 Days 4.86 % $4.73 $4.96
Chg 30 Days -9.32 % $5.47 $4.96
Chg 12 mos 104.96 % $2.42 $4.96
Trend - 3 mos 5.37 % Width: 26.61 %
Trend - 12 mos 70.64 % Width: 58.20 %
Pred. range - 3 mos $5.01 - $6.34 0.99 % - 27.86 %
Pred. range - 12 mos $6.53 - $10.32 31.58 % - 108.16 %
Short MA avg 3 mos Buy Nov 06, 2025 - 8 days
Long MA avg 3 mos Buy Nov 06, 2025 - 8 days
Short/Long MA avg 3 mos Sell Nov 05, 2025 - 9 days
Short MA avg 12 mos Buy Nov 06, 2025 - 8 days
Long MA avg 12 mos Buy Aug 06, 2025 - 73 days
Short/Long MA avg 12 mos Buy May 19, 2025 - 127 days
Pivot Short Sell Nov 10, 2025 - 6 days
Bollinger Buy Nov 10, 2025 - 6 days
MACD Sell No Dates Stored For This Signal

Signals Effectiveness

Backtesting is not only a way to check stock signal accuracy, but also a tool to continually improvement. Data can be used for self adjustment as each stock has an individual behavior.

Accuracy and return is not the same. A stock signal may provide low statistical accuracy, but the signals may prove high return in average.

Sharp market dips or fundamental changes (earning reports, news updates etc), may force a short term reaction and disturb the signals (Signals may jump quickly from buy to sell, just to return to buy).

Stock Score

Buy Signals
Sell Signals

Bollinger Bands

Buy Signals
Sell Signals

MACD

Buy Signals
Sell Signals

Moving Average (7d)

Buy Signals
Sell Signals
Click to get the best stock tips daily for free!
ABOUT PUMA BIOTECHNOLOGY INC
Puma Biotechnology
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advance...
GOLDEN STAR
Ticker Change Signal Date
UNIT
$6.00
4.83% Nov 04
TBPH
$14.14
27.58% Oct 23
A
AMIX
$1.12
2.68% Oct 23
COCO
$40.85
11.21% Oct 23
LAUR
$29.55
1.20% Oct 22

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE